Healthcare provider profile · identity verified

Irina Lev

Internal Medicine · BALTIMORE, MD · NPI 1215462791

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	279	113
Atorvastatin Calcium	Atorvastatin Calcium	268	104
Omeprazole	Omeprazole	222	89
Metformin Hcl Er	Metformin Hcl	208	64
Amlodipine Besylate	Amlodipine Besylate	204	80
Levothyroxine Sodium	Levothyroxine Sodium	189	72
Losartan Potassium	Losartan Potassium	171	63
Lisinopril	Lisinopril	154	60
Meloxicam	Meloxicam	145	54
Albuterol Sulfate Hfa	Albuterol Sulfate	125	76
Ozempic	Semaglutide	113	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	30
Simvastatin	Simvastatin	91	36
Trazodone Hcl	Trazodone Hcl	81	37
Alendronate Sodium	Alendronate Sodium	79	25
Gabapentin	Gabapentin	73	34
Metformin Hcl	Metformin Hcl	73	26
Prednisone	Prednisone	71	68
Metoprolol Tartrate	Metoprolol Tartrate	69	23
Hydrochlorothiazide	Hydrochlorothiazide	66	29
Tramadol Hcl	Tramadol Hcl	66	21
Atenolol	Atenolol	62	20
Jardiance	Empagliflozin	62	16
Ondansetron Odt	Ondansetron	59	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	52	51
Alprazolam	Alprazolam	50	16
Estradiol	Estradiol	47	22
Fluoxetine Hcl	Fluoxetine Hcl	47	15
Potassium Chloride	Potassium Chloride	47	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	suppressed
Sertraline Hcl	Sertraline Hcl	44	15
Furosemide	Furosemide	42	20
Azithromycin	Azithromycin	39	39
Cefadroxil	Cefadroxil	39	35
Allopurinol	Allopurinol	38	16
Tamsulosin Hcl	Tamsulosin Hcl	36	14
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	13
Pantoprazole Sodium	Pantoprazole Sodium	29	11
Acyclovir	Acyclovir	28	17
Triamcinolone Acetonide	Triamcinolone Acetonide	27	16
Ezetimibe	Ezetimibe	26	12
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Mirtazapine	Mirtazapine	25	11
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Ibuprofen	Ibuprofen	21	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	19	19
Bupropion Xl	Bupropion Hcl	18	11
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Nystatin	Nystatin	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Finasteride	Finasteride	17	suppressed
Metoprolol Succinate	Metoprolol Succinate	17	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Glipizide	Glipizide	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Alvesco	Ciclesonide	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	12	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	suppressed
Cequa	Cyclosporine	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error